Bionyra Pharma
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7-11 Boulevard Haussmann, Paris, Île-de-...Website
www.bionyra.comRevenue
<$5 MillionIndustry
About Bionyra Pharma
Bionyra Pharma Org Chart
Is Bionyra Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Bionyra Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Bionyra Pharma
Earning: See what the market has to say on Bionyra Pharma recently announced quarterly report
Funding: Get notified immidiatlly once Bionyra Pharma has new funding data
Product Launch: Get notified when Bionyra Pharma launches new products
Website visits: Recent activity has been detected on your website
Click to see if Bionyra Pharma had a recent Job posting/layoffs
Check out if Bionyra Pharma is spiking on competitors!
Bionyra Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Bionyra Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bionyra Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bionyra Pharma.
Bionyra Pharma financials insights
Gather financial insights about Bionyra Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$165M
Most Recent Scoops
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Bionyra Pharma
Bionyra Pharma is a clinical-stage biotechnology company developing next-generation biologic therapies for severe immune-mediated inflammatory diseases. The company focuses on advanced monoclonal and multispecific antibody programs designed to target key immune pathways and provide deeper, longer-lasting disease control. Its pipeline includes thera... Read More